Log In
Print
BCIQ
Print
Print this Print this
 

LMTX (TRx0237)

  Manage Alerts
Collapse Summary General Information
Company TauRx Pharmaceuticals Ltd.
DescriptionSecond-generation tau aggregation inhibitor
Molecular Target Microtubule-associated protein tau (tau) (MAPT) (FTDP-17)
Mechanism of ActionProtein aggregation inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today